About: Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also provides Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Emrosi for the treatment of inflammatory lesions of rosacea; Exelderm cream and solution for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $5.81 (-1.69%)
DERM NASDAQ Journey Medical Corp
Journey Medical Corp share price
DERM price activity
Last Price
$5.810
Change (24hr)
-0.10 USD (-1.69%)
Volume
140.49K
Volume (4w avg)
-
Open
$5.91
Day Range
$5.81 - $5.91
Previous Close
$5.91
Last Trade
13 Oct, 4:19 pm GMT+0
Delayed
13 Oct, 4:19 pm GMT+0
DERM price performance
Delayed
13 Oct, 4:19 pm GMT+0
DERM Market Signals